Crossmark

Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway

Crossref DOI link: https://doi.org/10.1186/s13046-019-1166-3

Published Online: 2019-04-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Wen-Chien

Kuo, Kuang-Tai

Wang, Chun-Hua

Yeh, Chi-Tai https://orcid.org/0000-0001-5189-9755
Wang, Yongjie
Funding

Funding for this research was provided by:

National Science Council (MOST-105-MY2-18-2215)
License Information

Text and Data Mining valid from 2019-04-29
More Information

Article History

Received: 7 November 2018

Accepted: 2 April 2019

First Online: 29 April 2019

Competing interest

: The authors declare that they have no potential financial competing interests that may in any way gain or lose financially from the publication of this manuscript at present or in the future. Additionally, no non-financial competing interests are involved in the manuscript.

: Clinical samples were collected from MacKay Memorial Hospital (Taipei City, Taiwan). All enrolled patients gave written informed consent for their tissues to be used for scientific research. The study was approved by the Institutional Review Board (IRB) of the MacKay Memorial Hospital, consistent with the recommendations of the declaration of Helsinki for biomedical research (MacKay Memorial Hospital Approval Number: 20160600011 16MMHIS073e) and followed standard institutional protocol for human research. Moreover, the animal study protocol was approved by the Animal Care and User Committee at MacKay Memorial Hospital (Affidavit of Approval of Animal Use Protocol # MMH-104-024).

: Not applicable.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below